NASDAQ:RADX

Healthcare·Investment Analysis·NASDAQ:RADX·News·Stock Market

RADX Shares Slip Ahead of Cancer-Imaging Update

Radiopharm Theranostics’ U.S.-listed shares last traded at $4.52, down 1.3% on volume of 325, as investors awaited new data from its lead cancer-imaging program. The company’s most recent update was a May 14 Zacks report, with topline Phase 2 trial results for RAD101 expected around the end of June. Radiopharm reported A$19.2 million in cash as of March 31.

May 21, 2026

Victorian government to tighten IVF clinic regulation after Monash IVF errors
June 1, 2026, 8:32 PM EDT. The Victorian government plans stricter regulations for IVF clinics following high-profile embryo mix-ups involving Monash IVF. Health Minister Harriet Shing will gain authority to cancel clinic registrations and enforce rigorous accreditation standards under a national framework led by the Australian Commission on Safety and Quality in Health Care. The moves aim to address inconsistencies in state regulations and improve patient safety with measures like performance metrics, workforce guidelines, and safety rules for new technologies. Clinics will face a standard three-year registration, subject to review or shortening if risks are identified. Additional powers include health department inspections and equipment seizures. The changes follow a government-initiated review revealing significant shortcomings in the IVF sector.